Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years
- PMID: 29314445
- PMCID: PMC6676479
- DOI: 10.1002/ejhf.1130
Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years
Figures
References
-
- Samman Tahhan A, Vaduganathan M, Kelkar A, Georgiopoulou VV, Kalogeropoulos AP, Greene SJ, Fonarow GC, Gheorghiade M, Butler J. Trends in heart failure clinical trials from 2001–2012. J Card Fail 2016;22: 171–179. - PubMed
-
- Butler J, Subacius H, Vaduganathan M, Fonarow GC, Ambrosy AP, Konstam MA, Maggioni A, Mentz RJ, Swedberg K, Zannad F, Gheorghiade M; EVEREST Investigators. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. J Am Coll Cardiol 2013;61: 571–579. - PubMed
-
- Ferreira JP, Girerd N, Rossignol P, Zannad F Geographic differences in heart failure trials. Eur J Heart Fail 2015;17:893–905. - PubMed
-
- Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O’Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation 2015; 131:34–42. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical